Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ResMed Inc (RMD)

  • Business News
  • June 26, 2025, 22:32 UTC
  • 0

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

Omnicell Inc (OMCL)

  • Business News
  • June 26, 2025, 21:55 UTC
  • 0

Omnicell - OmniSphere Receives HITRUST CSF (Common Security Framework) i1 Certification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • June 26, 2025, 21:46 UTC
  • 0

UTHR: Notification

Market reaction Comment Full text

Sarepta Therapeutics Inc (SRPT)

  • Business News
  • June 26, 2025, 21:25 UTC
  • 0

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • Business News
  • June 26, 2025, 21:15 UTC
  • 0

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Market reaction Comment Full text

Iovance Biotherapeutics Inc (IOVA)

  • Business News
  • June 26, 2025, 20:58 UTC
  • 0

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

TEVA (TEVA)

  • Business News
  • June 26, 2025, 20:31 UTC
  • 0

Teva Pharmaceutical Industries Ltd. - Teva Releases Q2 2025 Aide Memoire

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • June 26, 2025, 20:30 UTC
  • 0

Teva Releases Q2 2025 Aide Memoire

Market reaction Comment Full text

ProQR Therapeutics (PRQR)

  • Business News
  • June 26, 2025, 20:30 UTC
  • 0

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

Market reaction Comment Full text

Bausch&Lomb Corp (BLCO)

  • Business News
  • June 26, 2025, 20:30 UTC
  • 0

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

Market reaction Comment Full text
  • Previous
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next

Search

News categories

  • Technical Exchange News(9417)
  • Event(407)
  • SEC News(154536)
  • FDA Approval(8863)
  • Company Report(721)
  • Business News(105219)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin